Event Videos

https://www.ncbi.nlm.nih.gov/pubmed/29077642

J Pediatr Gastroenterol Nutr. 2017 Oct 27. doi: 10.1097/MPG.0000000000001815. [Epub ahead of print]

Long-Term Follow-up after Pediatric Liver Transplantation: Predictors of Growth.
Loeb N, Owens JS, Strom M, Farassati F, Van Roestel K, Chambers K, Kean P, Ng VL, Avitzur Y, Carricato M, Wales P, Martin GC.

Abstract

OBJECTIVES:

To describe long-term growth post-pediatric liver transplantation and to conduct bivariate and multivariate analysis of factors that may predict post-transplantation growth in children who received a liver transplant from January 1999 to December 2008 at the Hospital for Sick Children.

METHODS:

Published on: 
Oct-2017

https://www.ncbi.nlm.nih.gov/pubmed/29067750

Pediatr Int. 2017 Oct 25. doi: 10.1111/ped.13442. [Epub ahead of print]

Kikuchi R, Mizuta K, Urahashi T, Sanada Y, Yamada N, Onuma E, Sato I1, Kamibeppu K.

Abstract

BACKGROUND:

Health-related quality of life (HRQOL) is an important outcome in solid organ transplantation. This study evaluated and explored the factors of generic and transplant-specific HRQOL in Japanese pediatric and adolescent patients with biliary atresia (BA) after living donor liver transplant (LDLT).

METHODS:

Published on: 
Oct-2017

https://www.ncbi.nlm.nih.gov/pubmed/29081931 Cholestasis

Pediatr Rep. 2017 Oct 10;9(3):7266. doi: 10.4081/pr.2017.7266. eCollection 2017 Oct 6.

Atypical clinical presentation and successful treatment with oral cholic acid of a child with defective bile acid synthesis due to a novel mutation in the HSD3B7 gene. Bossi G, Giordano G, Rispoli GA, Maggiore G, Naturale M, Marchetti D, Iascone M.

Abstract

Published on: 
Oct-2017

https://www.ncbi.nlm.nih.gov/pubmed/29079315 \ Nutrition associated liver disease

J Pediatr Surg. 2017 Oct 12. pii: S0022-3468(17)30652-8. doi: 10.1016/j.jpedsurg.2017.10.030. [Epub ahead of print]

Gonzalez-Hernandez J, Prajapati P, Ogola G, Nguyen V, Channabasappa N, Piper HG.

Abstract

PURPOSE:

The purpose of this study was to compare outcomes of lipid minimization with either Intralipid (IL) or Omegaven® in children with intestinal failure (IF) who developed intestinal failure-associated liver disease (IFALD) while receiving parenteral nutrition (PN).

METHODS:

Published on: 
Oct-2017

https://www.ncbi.nlm.nih.gov/pubmed/29084519 NAFLD

BMC Public Health. 2017 Oct 30;17(1):851. doi: 10.1186/s12889-017-4868-5.

Waist-to-height ratio is a useful index for nonalcoholic fatty liver disease in children and adolescents: a secondary data analysis. Lin MS, Lin TH, Guo SE, Tsai MH, Chiang MS, Huang TJ, Chen MY.

Abstract

BACKGROUND:

Nonalcoholic fatty liver disease (NAFLD) is a global problem and pediatric obesity has risen dramatically. Early NAFLD might progress to nonalcoholic steatohepatitis (NASH) or liver cirrhosis and significantly increase liver disease-related mortality. We looked for NAFLD predictors in children and adolescents.

METHODS:

Published on: 
Oct-2017

https://www.ncbi.nlm.nih.gov/pubmed/29080393

Rom J Intern Med. 2017 Oct 26. pii: /j/rjim.ahead-of-print/rjim-2017-0040/rjim-2017-0040.xml. doi: 10.1515/rjim-2017-0040. [Epub ahead of print]

Bălănescu A, Bălănescu P, Comanici V, Stan I, Acs B, Prisăcariu L, Brezan F, Ciomârtan T, Gherghina I.

Abstract

BACKGROUND AND AIMS:

The aim of this study is to assess the lipid profile pattern of pediatric overweight and/or obese patients with Non-Alcoholic Fatty Liver Disease (NAFLD) in relation to IDF Consensus Criteria for Metabolic Syndrome (MetS).

MATERIAL AND METHODS:

Published on: 
Oct-2017

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: